Niv Edward Caviar
Vorstandsvorsitzender bei SpineOvations, Inc.
Ursprung des Netzwerks ersten Grades von Niv Edward Caviar
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 53 | |
Subsidiary | Medical Specialties | 10 | |
SpineOvations, Inc.
SpineOvations, Inc. Medical SpecialtiesHealth Technology SpineOvations, Inc. operates as a clinical-stage medical device company. It develops therapies to treat low back pain. The company was founded by Neville Alleyne and is headquartered in Carlsbad, CA.
5
| Private Company | Medical Specialties | 5 |
Subsidiary | Pharmaceuticals: Major | 4 | |
iTherX Pharmaceuticals, Inc.
iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world's population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. Currently there is only a single mode of therapy and less than 5% of patients can be successfully treated. The company continues to carry out focused research in their areas of expertise to provide sustainability of product pipelines. In an era of managed care and increased regulatory scrutiny, it is easy to yield to the temptation of producing 'me too drugs'. However, they think that innovation in the development of pharmaceutical products is important because it is the only way to improve the outcomes for patients. As such, they also think that innovation can ensure the financial returns that investors in health care deserve for the risks that they take. Their innovative approach is evident in their pipeline of Hepatitis C drug candidates. As new and better treatments are being sought, most companies involved in this effort are targeting the enzymes responsible for viral replication: polymerases and proteases. While these are important targets, there is a great deal of duplication of effort in these initiatives. At iTherX, they are pioneering the development of a novel class of HCV antivirals by targeting the steps involved in the entry of the hepatitis C virus into liver cells. Their Host Cell Receptor Target Program engenders small molecule compounds that target a liver cell membrane protein, SR-B1, which recognize and dock the virus. Their lead compound, ITX5061, has extensive safety data in over 250 patients, and shows picomolar potency in inhibiting HCV infection in vitro. They plan to initiate a Phase 2a clinical trial in HCV patients in Q2 of 2009. They have also used medicinal chemistry to develop back-up compounds for this program, and a clinical candidate has been selected for development. Another innovative program is novel cell receptor, which develops antagonists (including biologics) against a novel liver cell membrane protein required for infectivity of the virus.
3
| Extinct | Medical Distributors | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Niv Edward Caviar
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BMC SOFTWARE, INC. | Packaged Software | Human Resources Officer Director/Board Member | |
Inamed Corp.
Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Public Communications Contact Sales & Marketing | |
PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member Chairman | |
AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Director/Board Member | |
KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member | |
REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ion Torrent Systems, Inc.
Ion Torrent Systems, Inc. SemiconductorsElectronic Technology Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT. | Semiconductors | Director of Finance/CFO Corporate Officer/Principal | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
EVOLUS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal Graduate Degree | |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Doctorate Degree Graduate Degree | |
California State University-Fullerton | College/University | Undergraduate Degree Graduate Degree | |
Smith College
Smith College Other Consumer ServicesConsumer Services Smith College opened in 1875 with 14 students. Today, Smith is among the largest women’s colleges in Northampton, MA, with students from 48 states and 72 countries. The college remains strongly committed to the education of women at the undergraduate level, but Smith admits both men and women as graduate students. | College/University | Undergraduate Degree Undergraduate Degree | |
Syracuse University | College/University | Undergraduate Degree Masters Business Admin | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
North Carolina State University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Pepperdine University | College/University | Masters Business Admin Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of California, Irvine | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree | |
University of California, Santa Barbara | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
University of Iowa | College/University | Undergraduate Degree Graduate Degree | |
California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree Undergraduate Degree | |
University of the Witwatersrand | College/University | Graduate Degree Undergraduate Degree | |
Arnold & Mabel Beckman Foundation
Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Arnold & Mabel Beckman Foundation engages in the provision of support to young researchers. It focuses in the fields of chemistry and life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that open up new avenues of research and application in these sciences and related disciplines. It offers national programs and local community works. The company was founded by Arnold O. Beckman and Mabel Beckman in September 1977 and is headquartered in Irvine, CA. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member Director/Board Member | |
ACUCELA INC | Pharmaceuticals: Major | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Director/Board Member | |
SIENTRA, INC. | Medical Specialties | Chairman Director of Finance/CFO | |
HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman Corporate Officer/Principal | |
DERMIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Director/Board Member | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Founder | |
TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer |
Statistik
International
Vereinigte Staaten | 44 |
Vereinigtes Königreich | 4 |
Schweiz | 2 |
Frankreich | 2 |
Südafrika | 2 |
Sektoral
Health Technology | 28 |
Consumer Services | 20 |
Technology Services | 2 |
Commercial Services | 2 |
Electronic Technology | 2 |
Operativ
Director/Board Member | 312 |
Corporate Officer/Principal | 170 |
Independent Dir/Board Member | 86 |
Chairman | 68 |
Undergraduate Degree | 65 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Alexander Ingram | 43 |
Trevor Jones | 36 |
Louis Lavigne | 32 |
Dennis Podlesak | 27 |
Nader Naini | 26 |
William Humphries | 26 |
Russ Ray | 24 |
Grace Colón | 22 |
Deborah Dunsire | 20 |
Eric Brandt | 20 |
Karen Osar | 17 |
Christian Henry | 17 |
William F. Daly | 15 |
George Lasezkay | 14 |
Lauren Silvernail | 14 |
- Börse
- Insiders
- Niv Edward Caviar
- Unternehmensverbindungen